Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 3814-3827

  Beydoun, May A ^a   Boueiz, A ^b   Shroff, M R ^d   Beydoun, H A ^e   Wang, Y ^c   Zonderman, A B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; UNITED STATES; VITAMIN BLOOD LEVEL;

EID: 77955355501     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0410     Document Type: Article

References (85)

1. Mølgaard C, Michaelsen KF 2003 Vitamin D and bone health in early life. Proc Nutr Soc 62:823-828 (Pubitemid 38004978)
2. Smith P, Barzel US 1984 Vitamin D deficiency osteomalacia in elderly persons. Compr Ther 10:24-32 (Pubitemid 14031527)
3. Rizzoli R, Eisman JA, Norquist J, Ljunggren O, Krishnarajah G, Lim SK, Chandler J 2006 Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study. Int J Clin Pract 60:1013-1019 (Pubitemid 44082295)
4. Lips P 2007 Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 103:620-625 (Pubitemid 46401309)
5. Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J, Warburton EA 2006 Reduced vitamin D in acute stroke. Stroke 37:243-245
6. Giovannucci E, Liu Y, Hollis BW, Rimm EB 2008 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168:1174-1180 (Pubitemid 351831400)
7. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W 2008 Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340-1349 (Pubitemid 351930842)
8. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF 2006 The role of vitamin D in cancer prevention. Am J Public Health 96:252-261
9. Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, Lipkin M, Newmark H, Holick MF, Garland FC 2007 Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 103:708-711
10. Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM 2007 Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 167:1050-1059 (Pubitemid 46835793)
11. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E 2006 Epidemic influenza and vitamin D. Epidemiol Infect 134:1129-1140
12. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamäki H, Ylikomi T 2007 An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 86:714-717
13. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, Wright D, Latif M, Davidson RN 2000 Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 355:618-621
14. Autier P, Gandini S 2007 Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167:1730-1737
15. Avenell A, Cook JA, Maclennan GS, Macpherson GC 2007 Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, IS-RCTN 51647438). Age Ageing 36:574-577
16. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP 2007 Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85:1586-1591
17. Arunabh S, Pollack S, Yeh J, Aloia JF 2003 Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88:157-161
18. Auwerx J, Bouillon R, Kesteloot H 1992 Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb 12:671-674
19. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vázquez C, Escobar-Morreale HF 2007 Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 26:573-580
20. Forman JP, Curhan GC, Taylor EN 2008 Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 52:828-832
21. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC 2007 Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49:1063-1069
22. Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE 2006 Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 114:577-583 (Pubitemid 46087264)
23. Hyppönen E, Boucher BJ, Berry DJ, Power C 2008 25-Hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 57:298-305
24. Martini LA, Wood RJ 2006 Vitamin D status and the metabolic syndrome. Nutr Rev 64:479-486
25. Reis JP, von Mühlen D, Miller 3rd ER 2008 Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 159:41-48
26. Scragg R, Sowers M, Bell C 2004 Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27:2813-2818
27. Lind L, Hänni A, Lithell H, Hvarfner A, Sörensen OH, Ljunghall S 1995 Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8:894-901
28. Chonchol M, Scragg R 2007 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 71:134-139 (Pubitemid 46094686)
29. Looker AC 2005 Body fat and vitamin D status in Black versus white women. J Clin Endocrinol Metab 90:635-640
30. Scragg R, Sowers M, Bell C 2007 Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20:713-719 (Pubitemid 46936167)
31. Gannagé-Yared MH, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G 2009 Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 160:965-971
32. Pérez-López FR 2009 Vitamin D metabolism and cardiovascular risk factors in postmenopausal women. Maturitas 62:248-262
33. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K 2007 Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167:1159-1165
34. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F 2006 Dietary diversity score and cardiovascular risk factors in Tehranian adults. Public Health Nutr 9:728-736 (Pubitemid 46211747)
35. Guo X, Warden BA, Paeratakul S, Bray GA 2004 Healthy Eating Index and obesity. Eur J Clin Nutr 58:1580-1586
36. McCullough ML, Feskanich D, Rimm EB, Giovannucci EL, Ascherio A, Variyam JN, Spiegelman D, Stampfer MJ, Willett WC 2000 Adherence to the Dietary Guidelines for Americans and risk of major chronic disease in men. Am J Clin Nutr 72:1223-1231
37. McCullough ML, Feskanich D, Stampfer MJ, Giovannucci EL, Rimm EB, Hu FB, Spiegelman D, Hunter DJ, Colditz GA, Willett WC 2002 Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 76:1261-1271
38. Quatromoni PA, Copenhafer DL, D'Agostino RB, Millen BE 2002 Dietary patterns predict the development of overweight in women: the Framingham Nutrition Studies. J Am Diet Assoc 102:1239-1246
39. Quatromoni PA, Pencina M, Cobain MR, Jacques PF, D'Agostino RB 2006 Dietary quality predicts adult weight gain: findings from the Framingham Offspring Study. Obesity (Silver Spring) 14:1383-1391
40. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F 2005 Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr 82:523-530
41. Beydoun MA, Gary TL, Caballero BH, Lawrence RS, Cheskin LJ, Wang Y 2008 Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome. Am J Clin Nutr 87:1914-1925
42. Jaffiol C 2008 [Milk and dairy products in the prevention and therapy of obesity, type 2 diabetes and metabolic syndrome]. Bull Acad Natl Med 192:749-758 (French)
43. Beydoun MA, Wang Y 2009 Gender-ethnic disparity in BMI and waist circumference distribution shifts in US adults. Obesity (Silver Spring) 17:169-176
44. Speer G, Cseh K, Winkler G, Vargha P, Braun E, Takács I, Lakatos P 2001 Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol 144:385-389
45. Ye WZ, Reis AF, Dubois-Laforgue D, Bellanné-Chantelot C, Timsit J, Velho G 2001 Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol 145:181-186
46. Meng YX, Ford ES, Li C, Quarshie A, Al-Mahmoud AM, Giles W, Gibbons GH, Strayhorn G 2007 Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999-2002. Clin Chem 53:2152-2159
47. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Sari I, Yazici M, Kele̊ I 2006 Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 19:1055-1062
48. Piestrzeniewicz K, £uczak K, Komorowski J, Jankiewicz-Wika J, Goch JH 2007 Relation of C-reactive protein to obesity, adipose tissue hormones and cardiovascular risk factors in men treated with early percutaneous intervention in course of acute myocardial infarction. Neuro Endocrinol Lett 28:427-432
49. Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S 2005 Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28:1438-1444
50. Ford ES, Mokdad AH, Liu S 2005 Healthy Eating Index and C-reactive protein concentration: findings from the National Health and Nutrition Examination Survey III, 1988-1994. Eur J Clin Nutr 59:278-283
51. Fung TT, McCullough ML, Newby PK, Manson JE, Meigs JB, Rifai N, Willett WC, Hu FB 2005 Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 82:163-173 (Pubitemid 41716389)
52. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM 2006 Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:1549-1555
53. Proctor DN, O'Brien PC, Atkinson EJ, Nair KS 1999 Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol 277:E489-E495
54. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ 1993 Human blood pressure determination by sphygmomanometry. Circulation 88:2460-2470
55. Center for Disease Control and Prevention 2006 National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes.htm
56. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
57. Wallace TM, Levy JC, Matthews DR 2004 Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495
58. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
59. 2003 Handbook of diagnostic tests. 3rd ed. Philadelphia: Lippincott Williams & Wilkins
60. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH 1997 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979
61. U.S. Department of Agriculture 2005 Healthy Eating Index 2005. http://www.cnpp.usda.gov/Publications/HEI/healthyeatingindex2005factsheet.pdf
62. Cheng YJ, Gregg EW, De Rekeneire N, Williams DE, Imperatore G, Caspersen CJ, Kahn HS 2007 Muscle-strengthening activity and its association with insulin sensitivity. Diabetes Care 30:2264-2270
63. Lagerros YT, Lagiou P 2007 Assessment of physical activity and energy expenditure in epidemiological research of chronic diseases. Eur J Epidemiol 22:353-362
64. National Institutes of Health; National Heart, Lung, and Blood Institute; North American Association for the Study of Obesity 2000 The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD: National Institutes of Health
65. Lohr SL 1999 Sampling: design and analysis. Pacific Grove, CA: Duxbury Press
66. Hatcher L 1994 A step-by-step approach to using the SAS system for factor analysis ad structural equation modeling. Cary, NC: SAS
67. Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K, Stehle P, Koertke H, Koerfer R 2009 Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89:1321-1327
68. Chiu KC, Chu A, Go VL, Saad MF 2004 Hypovitaminosis D is associated with insulin resistance and β-cell dysfunction. Am J Clin Nutr 79:820-825
69. Johnson JA, Grande JP, Roche PC, Kumar R 1994 Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol 267:E356-E360
70. Simpson RU, Thomas GA, Arnold AJ 1985 Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 260:8882-8891
71. Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE, Hewison M 2004 Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89-90:121-125
72. Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, Jaccard N, Knoll E, Stern N 2005 25-Hydroxyvitamin D3-1α-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111:1666-1671
73. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF 2000 Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690-693
74. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S 1985 Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76:370-373 (Pubitemid 15243466)
75. Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R 2008 Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 47:87-91
76. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, Yanovski JA 2004 The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89:1196-1199
77. Zemel MB 2003 Role of dietary calcium and dairy products in modulating adiposity. Lipids 38:139-146
78. Pereira MA, Jacobs Jr DR, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS 2002 Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA 287:2081-2089
79. Li YC 2003 Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 88:327-331
80. Wang D, An SJ, Wang WH, McGiff JC, Ferreri NR 2001 CaR-mediated COX-2 expression in primary cultured mTAL cells. Am J Physiol Renal Physiol 281:F658-F664
81. Shiuchi T, Iwai M, Li HS, Wu L, Min LJ, Li JM, Okumura M, Cui TX, Horiuchi M 2004 Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension 43:1003-1010
82. Flegal KM, Shepherd JA, Looker AC, Graubard BI, Borrud LG, Ogden CL, Harris TB, Everhart JE, Schenker N 2009 Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr 89:500-508
83. Grundberg E, Brändström H, Ribom EL, Ljunggren O, Mallmin H, Kindmark A 2004 Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur J Endocrinol 150:323-328
84. Oh JY, Barrett-Connor E 2002 Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 51:356-359
85. Ortlepp JR, Lauscher J, Hoffmann R, Hanrath P, Joost HG 2001 The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med 18:842-845